Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Denny

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
The New Zealand Medical Journal|March 30, 2001
Turning off growth signals in tumours: a new approach to cancer chemotherapyW A Denny
Expert Opinion on Investigational Drugs|July 5, 2005
Topoisomerase targeted agents - chemistry to chemotherapyW A Denny
The Lancet. Oncology|March 22, 2002
The role of hypoxia-activated prodrugs in cancer therapyW A Denny
Idrugs : the Investigational Drugs Journal|May 10, 2008
ATP site-directed kinase inhibitorsW A Denny
European Journal of Medicinal Chemistry|October 16, 2001
Prodrug strategies in cancer therapyW A Denny
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinasesW A Denny
Drug Design and Delivery|July 1, 1988
New directions in the design and evaluation of anti-cancer drugsW A Denny
Idrugs : the Investigational Drugs Journal|August 30, 2005
Inhibitors of receptor protein kinasesW A Denny
Current Medicinal Chemistry|April 3, 2001
DNA minor groove alkylating agentsW A Denny
Expert Opinion on Investigational Drugs|July 2, 2005
The 134th British Pharmaceutical ConferenceW A Denny
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
The New Zealand Medical Journal|March 30, 2001
Turning off growth signals in tumours: a new approach to cancer chemotherapyW A Denny
Expert Opinion on Investigational Drugs|July 5, 2005
Topoisomerase targeted agents - chemistry to chemotherapyW A Denny
The Lancet. Oncology|March 22, 2002
The role of hypoxia-activated prodrugs in cancer therapyW A Denny
Idrugs : the Investigational Drugs Journal|May 10, 2008
ATP site-directed kinase inhibitorsW A Denny
European Journal of Medicinal Chemistry|October 16, 2001
Prodrug strategies in cancer therapyW A Denny
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinasesW A Denny
Drug Design and Delivery|July 1, 1988
New directions in the design and evaluation of anti-cancer drugsW A Denny
Idrugs : the Investigational Drugs Journal|August 30, 2005
Inhibitors of receptor protein kinasesW A Denny
Current Medicinal Chemistry|April 3, 2001
DNA minor groove alkylating agentsW A Denny
Expert Opinion on Investigational Drugs|July 2, 2005
The 134th British Pharmaceutical ConferenceW A Denny
Pageof 33